BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13410312)

  • 1. Neuroblastoma and related tumors.
    STOWENS D
    AMA Arch Pathol; 1957 May; 63(5):451-9. PubMed ID: 13410312
    [No Abstract]   [Full Text] [Related]  

  • 2. In situ neuroblastoma: an important concept related to the natural history of neural crest tumors.
    Shimada H
    Pediatr Dev Pathol; 2005; 8(3):305-6. PubMed ID: 16010489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
    Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
    Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
    Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma in adults. Pathologic findings and clinical outcome.
    Aleshire SL; Glick AD; Cruz VE; Bradley CA; Parl FF
    Arch Pathol Lab Med; 1985 Apr; 109(4):352-6. PubMed ID: 3885899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells.
    Laneve P; Di Marcotullio L; Gioia U; Fiori ME; Ferretti E; Gulino A; Bozzoni I; Caffarelli E
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7957-62. PubMed ID: 17483472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent pelvic neuroblastoma in an adult patient.
    Loeser A; Gerharz EW; Riedmiller H
    Gynecol Oncol; 2007 Jul; 106(1):257-8. PubMed ID: 17466361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the pathology of neuroblastoma (with illustrations on 8 cases)].
    CORRADINI E
    Arch De Vecchi Anat Patol; 1960 Oct; 33():731-81. PubMed ID: 13695645
    [No Abstract]   [Full Text] [Related]  

  • 12. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
    Tornóczky T; Kálmán E; Kajtár PG; Nyári T; Pearson AD; Tweddle DA; Board J; Shimada H
    Cancer; 2004 Jan; 100(2):390-7. PubMed ID: 14716776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Neuroblastoma Pathology Classification.
    Shimada H
    Pathologica; 2003 Oct; 95(5):240-1. PubMed ID: 14988991
    [No Abstract]   [Full Text] [Related]  

  • 15. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumors of the neuroblastoma group.
    Shimada H
    Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
    Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
    J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-3 and survivin expression in pediatric neuroblastoma and their roles in apoptosis.
    Wang JX; Zheng S
    Chin Med J (Engl); 2004 Dec; 117(12):1821-4. PubMed ID: 15603711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroblastoma: epidemiology, pathomorphological and molecular diagnosis, prognosis].
    Klepacka T; Michalak E; Ptaszyński K; Szeliga M; Liebhart M
    Przegl Lek; 2003; 60 Suppl 5():22-6. PubMed ID: 14575004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neuroblastoma stem cells.
    Ross RA; Spengler BA
    Semin Cancer Biol; 2007 Jun; 17(3):241-7. PubMed ID: 16839774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.